EGFR-IN-134
EGFR-IN-134 is a potent triazoloquinoline-based EGFR inhibitor (IC50: 0.023 μM) that exhibits anticancer activity by inducing apoptosis, necrosis, and G2/M cell cycle arrest. It modulates key apoptotic proteins, including downregulating Bcl-2 and upregulating p53, Bax, and caspases. This compound is a valuable tool for in vitro cancer research, particularly in studying EGFR-driven proliferation and cell death mechanisms.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Protein Biochemistry, Signal Transduction
Smiles
O=C (C1=NN (C2=CC=C ([N+] ([O-]) =O) C=C2) C3N1CCC4=C3C=C (OC) C (OC) =C4) /C=C/C5=CN (C6=CC=CC=C6) N=C5C7=CC=CC=C7
Molecular Formula
C36H30N6O5
Molecular Weight
626.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7040299-01 0.02 mg
Recombinant Schizosaccharomyces pombe Uncharacterized transcriptional regulatory protein PB24D3.01 (SPAPB24D3.01, SPAPB2C8.02)
Sign In for Pricing
View Details MBS7040299-02 0.1 mg
Recombinant Schizosaccharomyces pombe Uncharacterized transcriptional regulatory protein PB24D3.01 (SPAPB24D3.01, SPAPB2C8.02)
Sign In for Pricing
View Details MBS7040299-03 5x 0.1 mg
Recombinant Schizosaccharomyces pombe Uncharacterized transcriptional regulatory protein PB24D3.01 (SPAPB24D3.01, SPAPB2C8.02)
Sign In for Pricing
View Details